Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
TargetMol | Tags Metabolism
TargetMol | Tags Neuroscience

FAAH

Fatty acid amide hydrolase or FAAH (oleamide hydrolase, anandamide amidohydrolase) is a member of the serine hydrolase family of enzymes. It was first shown to break down anandamide in 1993. In humans, it is encoded by the gene FAAH.FAAH is an integral membrane hydrolase with a single N-terminal transmembrane domain. In vitro, FAAH has esterase and amidase activity.In vivo, FAAH is the principal catabolic enzyme for a class of bioactive lipids called the fatty acid amides (FAAs).

  • CB2R/FAAH modulator-2
    T677452876918-68-0
    CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-2 acts as a CB2R agonist and FAAH inhibitor, the Ki values are 10.8 and 152.9 nM for CB2R and CB1R, respectively, and the IC50 value for FAAH is 6.2 μM. CB2R/FAAH modulator-2 has studies research value related to cancer, deleterious inflammatory cascades occurring in neurodegenerative diseases, and COVID-19 infection.
    • $31
    In Stock
    Size
    QTY
  • Dual FAAH/sEH-IN-1
    T635362756099-59-7In house
    Dual FAAH/sEH-IN-1 is a dual inhibitor of sEH (soluble epoxide hydrolase) (IC50: 9.6 nM) and FAAH (fatty acid amide hydrolase) (IC50: 7 nM) with high affinity and anti-inflammatory activity.
    • $238
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • MK-4409
    T280591207745-58-1
    MK-4409 is a novel and selective inhibitor of oxazole fatty acid amide hydrolase FAAH.MK-4409 can be used to study inflammatory and neuropathic pain.
    • $293
    In Stock
    Size
    QTY
  • MM-433593
    T280761006604-91-6In house
    MM-433593 is a selective fatty acid amide hydrolase (FAAH-1) inhibitor for the treatment of pain, inflammation, and other disorders.
    • $293 TargetMol
    In Stock
    Size
    QTY
  • 2-Chlorophenylboronic acid
    T775133900-89-8
    2-Chlorophenylboronic acid is a monohalogenated phenylboronic acid, which is an important pharmaceutical intermediate and is widely used in the synthesis of new drugs.2-Chlorophenylboronic acid has an inhibitory effect on fatty acid amidase with a Ki value of 0.01-1 µM, and is used in the study of depression, glaucoma, neuropathic pain, anxiety, migraine, I diabetes and gastritis. , migraine, type I diabetes and gastritis.
    • $50
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • CB2R/FAAH modulator-1
    T67896928892-60-8
    CB2R/FAAH modulator-1, a cannabinoid type 2 receptor (CB2R) agonist, is also a fatty acid amide hydrolase (FAAH) inhibitor (IC50=4 μM) that reduces the production of pro-inflammatory and anti-inflammatory cytokines and is commonly used in inflammation studies. The Kis for CB2R and CB1R are 14.8 nM and 241.3 nM, respectively.
    • $117
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Biochanin A
    T2859491-80-5
    Biochanin A (4-Methylgenistein) is an isoflavone derivative isolated from red clover Trifolium pratense with anticarcinogenic properties. Biochanin A is a naturally occurring fatty acid amide hydrolase (FAAH) inhibitor.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • URB-597
    T6714546141-08-6
    URB-597 (FAAH Inhibitor II) is an effective, orally bioavailable FAAH inhibitor (IC50: 4.6 nM), and no effect on other cannabinoid-related targets.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • JNJ-42165279
    T32151346528-50-4
    JNJ-42165279 covalently inactivates the FAAH enzyme but is highly selective with regard to other enzymes, ion channels, transporters, and receptors. JNJ-42165279 (10 μM) exhibits high selectivity against a panel of 50 receptors, enzymes, transporters, and
    • $45
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • LY2183240
    T15802874902-19-9
    LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
    • $39
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • N-(3-Methoxybenzyl)Palmitamide
    T12139847361-96-0
    N-(3-Methoxybenzyl)Palmitamide is a promising FAAH inhibitor, treatment of pain, inflammation and CNS degenerative disorders.
    • $55
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • WWL 154
    T89271338574-93-8
    WWL 154 is an serine hydrolase (SH) and fatty acid amide hydrolase FAAH-4 inhibitor.
    • $63
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • CB2R/FAAH modulator-3
    T677472876918-67-9
    CB2R/FAAH modulator-3 (compound 27) is a modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-3 acts as a CB2R agonist and FAAH inhibitor, the Ki values are 20.1 and 67.6 nM for CB2R and CB1R, respectively, and the IC50 value for FAAH is 3.4 μM. CB2R/FAAH modulator-3 has research value related to cancer, deleterious inflammatory cascades occurring in neurodegenerative diseases, and COVID-19 infection.
    • $38
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • 4-Nonylphenylboronic acid
    T7688256383-45-6
    4-Nonylphenylboronic acid is a inhibitor of FAAH.
    • $40
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • BIA 10-2474
    T33541233855-46-3
    BIA 10-2474 is a long-acting reversible inhibitor of fatty acid amide hydrolase (FAAH) that increases levels of the neurotransmitter anandamide in the central nervous system and in peripheral tissues (that is, the rest of the body other than the brain and spinal cord). BIA 10-2474(BIA10-2474) interacts with the human endocannabinoid system. BIA 10-2474(BIA10-2474) was in development for the treatment of a range of different medical conditions from anxiety to Parkinson's disease, also for the treatment of chronic pain of multiple sclerosis, Y, hypertension or the treatment of obesity.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ARN272
    T5357488793-85-7
    ARN272 is a FAAH-like anandamide transporter (FLAT) inhibitor (IC50: 1.8 μM).
    • $39
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • N-​Benzyllinolenamide
    TN1965883715-18-2
    N-Benzyllinolenamide is a natural product. It is an inhibitor of fatty acid amide hydrolase (FAAH, IC50 of 41.8 μM).
    • $153
    In Stock
    Size
    QTY
  • FAAH-IN-1
    T112551242441-47-9
    FAAH-IN-1 is a fatty acid amide hydrolase (FAAH) inhibitor, with IC50s of 145 nM and 650 nM for rat and human FAAH, respectively.
    • $1,520
    Backorder
    Size
    QTY
  • Palmitoylisopropylamide
    T23119189939-61-5
    Palmitoylisopropylamide is a selective FAAH inhibitor that inhibits [H]-AEA uptake and cell proliferation at low concentrations.
    • $35
    In Stock
    Size
    QTY
  • FAAH-IN-2
    T15268184475-71-6
    FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent inhibitor of FAAH(fatty acid amide hydrolase).
    • $108
    In Stock
    Size
    QTY
  • Isopropyl dodec-11-enylfluorophosphonate
    T78674623114-64-7
    Isopropyl dodec-11-enylfluorophosphonate (IDEFP) is an organophosphorus ester functioning as a central cannabinoid receptor (CB1) antagonist and exhibits equipotent inhibition of fatty acid amide hydrolase (FAAH), with both activities possessing an IC50 value of 2 nM [1].
    • $288
    35 days
    Size
    QTY
  • AA38-3
    T937465815-76-1
    AA38-3 (1-Piperidinecarboxylic acid, 4-nitrophenyl ester) inhibites three SHs (ABHD6, ABHD11, and FAAH)
    • $39
    In Stock
    Size
    QTY
  • PF-04457845
    T43231020315-31-4
    PF-04457845 is a greatly and effctive FAAH inhibitor, and for hFAAH(IC50=7.2±0.63 nM) and rFAAH(IC50=7.4±0.62 nM).
    • $30
    In Stock
    Size
    QTY
  • SA57
    T128261346169-63-8
    SA57 is a potent, selective inhibitor of FAAH(IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH).
    • $78
    35 days
    Size
    QTY
  • PDP-EA
    T28353861891-72-7
    PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
    • $35
    In Stock
    Size
    QTY
  • FAAH inhibitor 1
    T11256326866-17-5
    FAAH inhibitor 1 (Benzothiazole analog 3) is an effective FAAH inhibitor with an IC50 of 18 nM.
    • $80
    In Stock
    Size
    QTY
  • VU534
    T77594923509-20-0
    VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism.
    • $36
    In Stock
    Size
    QTY
  • PF 750
    T16515959151-50-9
    PF 750 (ZINC27647189) is a selective and covalent inhibitor of FAAH. PF 750 shows IC50s varying from 16.2 to 595 nM in different incubation times.
    • $33
    In Stock
    Size
    QTY
  • JP104
    T78593887264-45-1
    JP104 is an aryl carbamate that irreversibly inhibits fatty acid amide hydrolase (FAAH) with a pIC50 value of approximately 8 [1].
    • $113
    35 days
    Size
    QTY
  • 1-Monomyristin
    T4859589-68-4
    1-Monomyristin (2,3-Dihydroxypropyl tetradecanoate) , a 1-monoglyceride of myristic acid, has antibacterial activity against several Gram-positive bacterial strains. 1-Myristoyl-rac-glycerol is used in colloidal chemistry as a nonionic surfactant in the development of micelles.
    • $39
    In Stock
    Size
    QTY
  • Carprofen
    T132553716-49-7
    Carprofen (Ridamyl) is a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities.
    • $36
    In Stock
    Size
    QTY
  • PF-3845
    T60431196109-52-0
    PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2.
    • $35
    In Stock
    Size
    QTY
  • JZL195
    T23381210004-12-8
    JZL195 is a selective and efficacious dual FAAH/MAGL inhibitor.
    • $39
    In Stock
    Size
    QTY
  • AM 374
    T6849286855-26-7
    AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research.
    • $39
    In Stock
    Size
    QTY
  • JNJ-1661010
    T2684681136-29-8
    JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2.
    • $39
    In Stock
    Size
    QTY
  • N-Benzylpalmitamide
    T3S210574058-71-2
    N-Benzylpalmitamide (Macamide 1) inhibits fatty acid amide hydrolase (FAAH) in a time-dependent manner and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders.
    • $30
    In Stock
    Size
    QTY
  • SA 47
    T16847792236-07-8
    SA 47 is a selective and effective inhibitor of fatty acid amide hydrolase and carbamate.
    • Inquiry Price
    Size
    QTY
  • URB937
    T86461357160-72-5
    URB937 is an inhibitor of FAAH and increases anandamide levels(IC50 : 26.8 nM).
    • $42
    In Stock
    Size
    QTY